Bohring-Opitz Syndrome for the Purpose of a Case and Review of the Topic

α
Daniela Alejandra Tolosa Quintero
Daniela Alejandra Tolosa Quintero
σ
Carolina Rivera Nieto
Carolina Rivera Nieto
ρ
Juan Sebastián Leguizamón Melo
Juan Sebastián Leguizamón Melo
α Cardioinfantil Foundation

Send Message

To: Author

Bohring-Opitz Syndrome for the Purpose of a Case and  Review of the Topic

Article Fingerprint

ReserarchID

VIN78

Bohring-Opitz Syndrome for the Purpose of a Case and  Review of the Topic Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Abstract

The Bohring-Opitz syndrome (BOPS) was first described in 1999 by Bohring et al (1). It is an extremely rare genetic condition, of unknown prevalence, which is caused by de novo or nonsense mutations in the ASXL1 gene. To date 46 people with BOPS have been described, of whom only 20 have a confirmed molecular diagnosis. The BOPS diagnosis is established by clinical suspicion and / or identification of a constitutional heterozygous pathogenic variant in the ASXL1 gene (2). This article shows the first case in Latin America of BOPS confirmed by molecular diagnosis.

References

12 Cites in Article
  1. Rob Hastings,Jan-Maarten Cobben,Gabriele Gillessen-Kaesbach,Judith Goodship,Hanne Hove,Susanne Kjaergaard,Helena Kemp,Helen Kingston,Peter Lunt,Sahar Mansour,Ruth Mcgowan,Kay Metcalfe,Catherine Murdoch-Davis,Mary Ray,Marlène Rio,Sarah Smithson,John Tolmie,Peter Turnpenny,Bregje Van Bon,Dagmar Wieczorek,Ruth Newbury-Ecob (2010). Bohring–Opitz (Oberklaid–Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis.
  2. B Russell,W-H Tan,J Graham (2018). Bohring-Opitz Syndrome.
  3. A Hoischen,Bwm Van Bon,B Rodríguez-Santiago,C Gilissen,Lelm Vissers,P De Vries (2011). De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.
  4. Silvana Dangiolo,Ashley Wilson,Vaidehi Jobanputra,Kwame Anyane‐yeboa (2015). Bohring–Opitz syndrome (BOS) with a new <i>ASXL1</i> pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome.
  5. Pamela Magini,Matteo Monica,Maria Uzielli,Patrizia Mongelli,Gloria Scarselli,Eleonora Gambineri,Gioacchino Scarano,Marco Seri (2012). Two novel patients with Bohring–Opitz syndrome caused by de novo <i>ASXL1</i> mutations.
  6. G Gillessen-Kaesbach,Bohring -Opitz (2014). Oberklaid -Danks) syndrome : Clinical study, review of the literature , and discussion of possible pathogenesis.
  7. G Oudesluijs,D Grange,A Bohring,G Zampino,P Thierry (2006). New Cases of Bohring -Opitz Syndrome, Update, and Critical Review of the Literature.
  8. Tjitske Kleefstra,Annette Schenck,Jamie Kramer,Hans Van Bokhoven (2014). The genetics of cognitive epigenetics.
  9. Arh Simpson,Cea Gibbon,A G Quinn,P Turnpenny (2007). Infantile high myopia in Bohring-Opitz syndrome.
  10. B Russell,J J Johnston,L Biesecker,N Kramer,A Pickart,W Rhead (2015). Clinical Management of Patients with ASXL1 Mutations and Bohring -Opitz Syndrome , Emphasizing the Need for Wilms Tumor Surveillance.
  11. M-Y Sheng,Y Zhou,M-J Xu,F-C Yang (2014). Role of ASXL1 mutation in myeloid malignancies.
  12. Colleen Carlston,Anne O'donnell-Luria,Hunter Underhill,Beryl Cummings,Ben Weisburd,Eric Minikel,Daniel Birnbaum,Tatiana Tvrdik,Daniel Macarthur,Rong Mao (2017). Pathogenic <i>ASXL1</i> somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz Syndrome.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Daniela Alejandra Tolosa Quintero. 2019. \u201cBohring-Opitz Syndrome for the Purpose of a Case and Review of the Topic\u201d. Global Journal of Medical Research - F: Diseases GJMR-F Volume 19 (GJMR Volume 19 Issue F2): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-F Classification: NLMC Code: QU 450
Version of record

v1.2

Issue date

March 15, 2019

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 2855
Total Downloads: 1446
2026 Trends
Related Research

Published Article

The Bohring-Opitz syndrome (BOPS) was first described in 1999 by Bohring et al (1). It is an extremely rare genetic condition, of unknown prevalence, which is caused by de novo or nonsense mutations in the ASXL1 gene. To date 46 people with BOPS have been described, of whom only 20 have a confirmed molecular diagnosis. The BOPS diagnosis is established by clinical suspicion and / or identification of a constitutional heterozygous pathogenic variant in the ASXL1 gene (2). This article shows the first case in Latin America of BOPS confirmed by molecular diagnosis.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Bohring-Opitz Syndrome for the Purpose of a Case and Review of the Topic

Daniela Alejandra Tolosa Quintero
Daniela Alejandra Tolosa Quintero Cardioinfantil Foundation
Carolina Rivera Nieto
Carolina Rivera Nieto
Juan Sebastián Leguizamón Melo
Juan Sebastián Leguizamón Melo

Research Journals